iTonic Holdings (ITOC) Other Accumulated Expenses (2023)

iTonic Holdings' (ITOC) quarterly Other Accumulated Expenses came in at $985043.0 in Q4 2023.

iTonic Holdings (ITOC) Other Accumulated Expenses (2023) Analysis & Trends

iTonic Holdings has disclosed Other Accumulated Expenses across 1 years of filings, most recently posting $985043.0 for Q4 2023.

Other Accumulated Expenses for Q4 2023 came in at $985043.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $985043.0 (changed N/A YoY), and the FY2023 annual result was $985043.0, changed N/A from the prior year.
Other Accumulated Expenses came in at $985043.0 for Q4 2023 at iTonic Holdings.
In the past five years, Other Accumulated Expenses ranged from a high of $985043.0 in Q4 2023 to a low of $985043.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	iTonic Holdings	5.23 Mn	4.31 Mn	-

Download Data

Date	Value
Dec 31, 2023	985,043.00